Orchid Says Roche's Boniva Patents Invalid

Law360, New York (November 9, 2007, 12:00 AM EST) -- Orchid Chemicals & Pharmaceuticals Ltd., one of the companies hit with a patent suit by Hoffman La-Roche for trying to horn in on the market for the osteoporosis drug Boniva, has filed a counterclaim alleging that the two patents Roche asserted against it are invalid.

On Thursday, India-based Orchid lodged its answer and counterclaim with the U.S. District Court for the District of New Jersey, asking the judge overseeing the dispute to declare that Orchid does not and has not infringed two Roche patents, and that...
To view the full article, register now.